Nucleosides. CXXXV. Synthesis of some 9-(2-deoxy-2-fluoro-B-D-arabinofuranosyl)-9H-purines and their biological activities Journal Article


Authors: Chu, C. K.; Matulic-Adamic, J.; Huang, J. T.; Chou, T. C.; Burchenal, J. H.; Fox, J. J.; Watanabe, K. A.
Article Title: Nucleosides. CXXXV. Synthesis of some 9-(2-deoxy-2-fluoro-B-D-arabinofuranosyl)-9H-purines and their biological activities
Abstract: Seven purine nucleosides containing the 2'-deoxy-2'-fluoro-/?-D-arabinofuranosyl moiety were synthesized and tested for their antitumor activity. Direct condensation of 3-0-acetyl-5-0-benzoyl-2-deoxy-2-fluoro-D-arabinofuranosyl bromide (1) with A^-benzoyladenine in CH2C12followed by saponification of the product afforded the adenine nucleoside (I, 2'-F-ara-A). Deamination of I with NaN02in HOAc gave the hypoxanthine analogue (II, 2'-F-ara-H). The 6-thiopurine nucleoside (III, 2'-F-ara-6MP) was prepared by condensation of 1 with 6-chloropurine by the mercury procedure followed by thiourea treatment and saponification of the product. Methylation of III gave the 6-SCH3 analogue (IV). Raney Ni desulfurization of III afforded the unsubstituted purine nucleoside (V, 2'-F-ara-P). Condensation of 1 with 2-acetamido-6-chloropurine by the silyl procedure afforded the protected 2-acetamido-6-chloropurine nucleoside which served as the precursor for both the guanine and 6-thioguanine nucleosides (VI, 2'-F-ara-G and VII, 2'-F-ara-TG, respectively). Thus, alkaline hydrolysis of the precursor gave VI. Thiourea treatment prior to alkaline hydrolysis gave VII. The new nucleoside, 2'-F-ara-G (VI) is found to be selectively toxic to human T-cell leukemia CCRF-CEM. © 1989, The Pharmaceutical Society of Japan. All rights reserved.
Keywords: leukemia; unclassified drug; human cell; nonhuman; antineoplastic agents; animal cell; mouse; animal; mice; biological model; cytotoxicity; drug synthesis; chemistry; cell culture; nuclear magnetic resonance; protozoon; antiviral agents; arabinonucleosides; purine nucleosides; leishmania; human; support, non-u.s. gov't; support, u.s. gov't, p.h.s.; 2' deoxy 2' fluorovidarabine; 2' fluoro 2' deoxyhypoxanthine arabinoside; 2-fluoro-arabinosylguanine antitumor activity; nucleoside purine nucleoside 2',-fluoro-arabinosylpurine; 2' deoxy 2' fluoroguanine arabinoside; 2' deoxy 2' fluorothioguanine arabinoside; 2' fluoro 2' deoxypurine arabinoside; cell strain ccrf cem
Journal Title: Chemical and Pharmaceutical Bulletin
Volume: 37
Issue: 2
ISSN: 0009-2363
Publisher: Pharmaceutical Society of Japan  
Date Published: 1989-02-01
Start Page: 336
End Page: 339
Language: English
DOI: 10.1248/cpb.37.336
PUBMED: 2743479
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 14 April 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ting-Chao Chou
    319 Chou
  2. Kyoichi A Watanabe
    125 Watanabe
  3. Jack J. Fox
    27 Fox